Adamis Pharmaceuticals Co...

NASDAQ: ADMP · Real-Time Price · USD
0.78
0.01 (1.50%)
At close: Sep 07, 2023, 9:59 PM

Adamis Pharmaceuticals Revenue

Adamis Pharmaceuticals reported an annual revenue of $4.76M, reflecting a 115.34% growth. For the quarter ending September 30, 2023, Adamis Pharmaceuticals generated $9.06M in revenue.
Revenue (ttm)
4.76M
Revenue Growth
115.34%
Price / Sales Ratio
5.33
Revenue / Employee
432.37K
Employees
11
Market Cap
7.25M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2022 4.76M +115.34%
Dec 31, 2021 2.21M -86.64%
Dec 31, 2020 16.53M -25.26%
Dec 31, 2019 22.11M +46.58%
Dec 31, 2018 15.09M +15.40%
Dec 31, 2017 13.07M +101.94%
Dec 31, 2016 6.47M +Infinity%
Dec 31, 2015 0 n/a
Mar 31, 2014 0 n/a
Mar 31, 2013 0 n/a
Mar 31, 2012 0 n/a
Mar 31, 2011 0 -100.00%
Mar 31, 2010 290.29K -56.02%
Mar 31, 2009 660K +Infinity%
Dec 31, 2008 0 n/a
Dec 31, 2007 0 -100.00%
Dec 31, 2006 2.66M -79.27%
Dec 31, 2005 12.84M +394.34%
Dec 31, 2004 2.6M +60.27%
Dec 31, 2003 1.62M +15.58%
Jan 13, 2003 1.4M +59.73%
Dec 31, 2001 877.49K -44.66%
Dec 31, 2000 1.59M +58.56%
Dec 31, 1999 1M +25.00%
Dec 31, 1998 800K n/a
Dec 31, 1997 800K +33.33%
Dec 31, 1996 600K -40.00%
Dec 31, 1995 1M +Infinity%
Dec 31, 1994 0 -100.00%
Dec 31, 1993 90K n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.